Skip to main content
Makers Laboratories Ltd. logo

Makers Laboratories Ltd. — Investor Relations & Filings

Ticker · 506919 ISIN · INE987A01010 LEI · 3358003XJ6DLKIEJCG14 BSE.NS Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country IN India
Listing BSE.NS 506919

About Makers Laboratories Ltd.

https://www.makerslabs.com/

Makers Laboratories Ltd. specializes in the manufacturing and marketing of a broad spectrum of pharmaceutical formulations. The company’s product range covers multiple therapeutic areas, including anti-malarials, ophthalmics, anti-diabetics, cardiovascular, and gastrointestinal health. Its manufacturing capabilities encompass various dosage forms such as tablets, capsules, oral liquids, and topicals. The company focuses on delivering high-quality generic medicines and maintains specialized marketing divisions to cater to diverse medical needs. By leveraging established manufacturing processes and quality control systems, the company aims to provide accessible healthcare solutions across its target therapeutic segments.

Recent filings

Filing Released Lang Actions
Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
Regulatory Filings Classification · 80% confidence The document is a notice under SEBI Regulation 29 to the stock exchange announcing a Board meeting date for considering and taking on record the audited financial results. It does not contain the financial results themselves, nor is it a management change or dividend notice. It is a regulatory compliance announcement rather than the report itself or its publication with attachments. Therefore, it best fits the catch-all Regulatory Filings (RNS) category.
2026-05-05 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended March 31, 2026. It is a compliance certificate issued by the Registrar and Share Transfer Agent to the company and filed with the stock exchange. The document is short (3091 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is not an announcement of a report but a certificate confirming regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and regulatory confirmations.
2026-04-06 English
Closure of Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice from Makers Laboratories Ltd. informing the stock exchange about the closure of the trading window for insiders due to the upcoming declaration of audited financial results for the fiscal year ending March 31, 2026. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The document does not contain any financial data or the actual financial results but is an announcement related to trading restrictions ahead of financial results. The document length is only 1525 characters, which is quite short and fits the pattern of a regulatory announcement rather than a full report. Therefore, it is best classified as a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into other specific categories like Annual Report or Earnings Release.
2026-03-16 English
Copy of Newspaper Publication
Earnings Release Classification · 95% confidence The document is a letter addressed to the stock exchange secretary, dated February 11, 2026, enclosing copies of the unaudited financial results for the 3rd quarter and nine months ended December 31, 2025. It references Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which govern disclosure of financial results. The document includes an extract of unaudited consolidated financial results with detailed financial figures for the quarter and nine months ended December 31, 2025, and also mentions that the full format of financial results is available on the stock exchange and company websites. The document is a public announcement of quarterly financial results, including key financial highlights and earnings per share, but it is not a full interim or quarterly report with comprehensive financial statements and analysis. It is also not a certification or attestation letter. Given the nature of the document as an initial announcement of quarterly financial results with key highlights, it fits the definition of an Earnings Release (ER).
2026-02-11 English
Standalone and Consolidated Financial Results for 3rd quarter and nine months ended 31.12.2025
Regulatory Filings
2026-02-10 English
Standalone and Consolidated Financial Results for 3rd quarter and nine months ended 31.12.2025
Regulatory Filings
2026-02-10 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.